Abdelfattah Hassan

Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibition

Abdelfattah Hassan, Mohamed Badr, Heba A. Hassan et al. · Bioorganic & Medicinal Chemistry · 2021 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Design and biological evaluation of 3-substituted quinazoline-2,4(1 <i>H</i> ,3 <i>H</i> )-dione derivatives as dual c-Met/VEGFR-2-TK inhibitors

Abdelfattah Hassan, Fawzy A. F. Mubarak, Ihsan A. Shehadi et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2023 · 29 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities

Hamada Hashem, Abdelfattah Hassan, Walid M. Abdelmagid et al. · Pharmaceuticals · 2024 · 29 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffold

Abdelfattah Hassan, Mohamed Badr, Dalia Abdelhamid et al. · Bioorganic Chemistry · 2022 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Novel 3-phenylquinazolin-2,4(1H,3H)-diones as dual VEGFR-2/c-Met-TK inhibitors: design, synthesis, and biological evaluation

Abdelfattah Hassan, Ahmed Mohamed Mosallam, Amal O. A. Ibrahim et al. · Scientific Reports · 2023 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14